Zurn Elkay (ZWS) Analyst Takeaways: Organic Growth, Margin Expansion, and Key Risks

Zurn Elkay (ZWS) reported Q4 organic sales growth and margin expansion, supported by supply chain optimization, disciplined pricing, and productivity gains from its business system. The stock rose to $52.50 from $47.06, reflecting positive sentiment despite softness in residential and some nonresidential segments. Analysts will closely evaluate: (1) adoption rates of new products like Pro Filtration; (2) transition away from China and its impact on margins; and (3) pace of entry into institutional and waterworks verticals. Pricing discipline and institutional market strength will be key performance metrics.